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A method using contrast two-dimensional echocardiog-
raphy for left ventricular chamber and myocardial opac-
ification from a right-sided pulmonary capillary wedge
position is described. A total of 152 studies were carried
out in nine mongrel dogs. Four different catheters with
different catheter tip cross-sectional areas (varying from
0.75 to 2.3 mnr') were used. In addition, catheter po-
sition (six different positions in the pulmonary circula-
tion), pressure of injection and type of echo contrast
agent (hand-agitated and sonicated) were studied.
In all 152 studies, two independent observers agreed
that echo contrast was seen in the left ventricular cham-
ber after a pulmonary capillary wedge injection of 8 cc
of echo contrast agent followed by a flush injection of 8
cc saline solution. In 71% of the studies, the two inde-
pendent observers agreed about the degree of opacifi-
cation on a qualitative scale of 0 to 3 + .
Time from injection from the catheter tip to the ap-
pearance of echo contrast in the left atrium was 6.2 ±
4.8 seconds for sonicated Renografin-76 and 2.8 ± 0.6
seconds for sonicated sorbitol 70% (p < 0.05). Corre-
lation for the disappearance rate of echo contrast as
Attempts have been descnbed recently to apply right-sided
mjections of echo contrast agents for two-dimensional con-
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determined for the region in the mid left ventricular
chamber and thermodilution cardiac output was fair
(r = -0.78; n =14). In 24 studies, it was not possible
to demonstrate the appearance of echo contrast in the
myocardium.
Peak videointensity of 10 duplicate injections showed
a mean percent error of 10.4 ± 2.1% for sonicated
Renografin-76 and 1.4 ± 0.8% for sonicated sorbitol
70%. For both agents, peak video intensity decreased
by 15.1 ± 2.3% after 12 consecutive injections. In con-
trast, the hand-agitated agents showed a striking de-
crease of 50% of peak video intensity after a minimum
of three consecutive injections. Echo contrast extrava-
sation was noted in 3 of the 152 studies by fluoroscopy
and confirmed by microscopic analysis; however, hemo-
dynamic and electrocardiographic changes were not seen.
Thus, transpulmonary opacification of the left ven-
tricular chamber and to a lesser degree of the left ven-
tricular myocardium is feasible. Furthermore, the pro-
cedure causes no serious side effects, is reproducible and
repeatable. The ultimate success is highly dependent on
the echo contrast agent and catheter used.
trast opacification of the left ventncular chamber (1-3)
These studies revealed significant hrmtauons due to physical
properties of available echo contrast agents, requmng pow-
erful injections from a pulmonary wedge position and car-
drac catheterization using conventIonal angrocardrographic
catheters (2,3)
Emphasis III our laboratory has been directed at the de-
velopment of newer echo contrast agents that feature smaller
microbubble sizes and longer echo contrast persistence (4)
ThIS report descnbes a recently evolved procedure that al-
lows left ventncular and also myocardial opacification by
means of a transpulmonary approach uSlllgthese newer echo
contrast agents Data on the reproducibility, repeatability
and toxicity of this method are reported and ItS potential
expenmental and cluneal applications are discussed
0735-1097/84/$300
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Table 1. Charactenstics of the Echo Contrast Agents
Experimental preparation. The study was performed
In nine mongrel dogs weighmg 25 to 35 kg Each dog was
placed on a special table to facilitate echocardiographic and
fluoroscopic studies Anesthesia was Induced by adrmrnster-
mg Intravenous sodium pentobarbital (35 mgikg body weight)
20 mmutes after 1 mglkg of Intramuscular morphme sulfate
Hepann (1,000 IU) was given mtravenously before mstru-
mentation, followed by 3,000 IV every 3 hours Supple-
mental pentobarbital was administered when required Dnp
infusion of saline solution throughout the expenment was
at a rate of 150 mllh Respiranon was mamtamed with a
Harvard respirator An 8F Cordis catheter was placed In the
aortic root for measurements of aortic pressure, and a 7F
Swan-Ganz thermodilution catheter was advanced mto the
pulmonary artery to obtain pressure and cardiac output mea-
surements Electrocardiograms were contmuously mom-
tored on an Electrorucs for Medicine recorder, as were aortic
and pulmonary artery pressures usmg Statham P23Db trans-
ducers Cardiac output was measured by thermodrlution
(Amencan Edwards Laboratones) For the study of left ven-
tncular echo contrast opacification, several catheters were
used with different external cross-sectional areas as follows
a 7F tnple lumen thermodilution Swan-Ganz catheter (0 75
mrrr'). a 7F USCI flow-directed double lumen catheter (l 8
mnr'), an 8F Swan-Ganz flow-directed angiographic cath-
eter (2 3 mrrr') and a 7F conventional Cordis angiocardio-
graphic catheter (1 8 mrrr')
Protocol. For each expenment, two of the catheters Just
descnbed were used at two different SItes In a penpheral
branch of the pulmonary artery where pulmonary artery
pressure could be registered with a deflated balloon. After
all catheters were advanced to their required Sites, a penod
of 30 minutes was allowed for stabihzation of the animal's
condinon Echo contrast Injections (8 cc) were made from
a pulmonary wedge position with the balloon mflated dunng
the mjection and released directly after the injection, fol-
lowed by a flush injection of 8 cc of saline solution with
the balloon deflated Each mjection was repeated twice, and
after every mjection the site of mjection was exammed by
fluoroscopy for extravasation of mjectate usmg 1 cc of Ren-
ografin-76 In two expenments, all mjections were per-
formed by Simultaneous registration of fluoroscopy and two-
dimensional echocardiography Based on our m Vitro ob-
servations (4), the present study evaluated only a limited
number of echo contrast agents (Table 1). Dunng 24 mjec-
nons, hand Injections were compared With power mjections
made by a pump Injector (Medtrad) at both 18 and 30 kgl
crrr' for the same rates of injection (varymg from 1 to 10
cc/s) To check If high power injections would result In
better echo Image quality, a total of eight hand mjections
were compared WIthan Injection from an OMP 3700 injector
at a fixed rate of 8 ccls After each expenment, the lungs
Renogratm-76 Sorbitol 70%
Microbubble size (IJ-) IO ± 6 (S) 6 ± 2 (S)
16 ± 13 (H) 23 ± 24 (H)
Persistence (seconds) 208 ± 62 (S) > 3 nun (S)
115 ± 28 (H) > 3 mm (H)
H = hand-agitated. S = sorucated
were examined for vascular damage by macroscopic and
microscopic investigation To facilitate mrcroscopic study,
methylene blue dye was mjected through the catheters mto
the sites of mjecnon Just before sacnfice of the animal
Methods of preparation of echo contrast agents. Hand
aguauon WIth two synnges connected by a three-way stop-
cock, mixtures of certain solutions were forcibly flushed
back and forth, approximately 15 to 20 times until sufficient
agitation was produced A small amount of air was mtro-
duced Into a synnge before the flushing to serve as a source
of air for microbubble development
Sonication The Heat Systems SOnicator (model W-375)
With a lead zirconate-titanate electrostncnve (ptezoelectnc)
crystal served as a controlled source of ultrasonic energy
Introduction of the tip of the SOnicator hom mto a solunon
resulted m cavitation that created nucrocavines of dissolved
gas and mert particles withm the hquid as a result of pow-
erful ultrasonic compression and rarefaction that overcome
the tensile strength of the liquid After the cavitation bubbles
collapsed, Immediately on cessation of the ultrasonic en-
ergy, a second generation of rrucrobubbles was created
from the released cavitation gas bubbles For the present
study, Renografin-76 (100% strength) and sorbitol 70% were
used
Echocardiographic technique. Two-dimensional
echocardiograpluc Images were obtamed as descnbed earlier
(5) USIng a 3 MHz transducer (Mark III, Advanced Tech-
nology Laboratones) In bnef, the dog was placed on ItS
nght side on a table With a special cutout to allow the
transducer to be directed from the bottom upward against
the nght Side of the chest. pomtmg at the site of maximal
cardiac pulsanon
Short-axis Images from five different levels of the left
ventncle were obtamed, and the long-axis two-dimensional
Image was registered by rotatmg and nltmg the transducer
90° until an Image could be recorded that showed both the
mitral valve onfice and the onfice of the pulmonary veins
mto the left atnum (Fig 1) Special attention was taken not
to change gain settmgs of the Instrument after an optimal
control Image was achieved All measurements were re-
corded on Videotape (VHS) and analyzed after completion
of the study for the appearance and bnghtness of echo con-
trast by VIsual mspecnon and by continuous videodensitorn-
etnc measurements (6) usmg our computer system
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Figure 1. Long-axis two-dimensional echocardiographic
image (stop frames) from theleft ventricle atfour different
times in the cardiac cycle (left) and a diagrammatic rep-
resentation (right). The illustrations indicate the appear-
ance of echo contrast at the left side of the heart after a
pulmonary capillary wedge injection and the pattern of
left ventricular and left atrial flow (arrowsin diagramat
right). LA = left atrium; LV = left ventricle; PV =
pulmonary vein.
Analysis of echo contrast images. Left ventricular
chamber echo contrast opacification was graded by visual
inspection by two independentobservers using a qualitative
scale from 0 to 3+, in which I + represents faint left
ventricular opacification and 3 + represents full opacifica-
tion of the left ventricle, including the left ventricularapex.
For quantitative analysis, the video intensity of the echo
contrast was measured after the contrast appeared in the
left atrium. Such an analysis provided true changes of video
intensity from which an echo contrast disappearance curve
could be constructed (7). Echo contrast appearanceand dis-
appearance curves from four different regions of interest
were constructed: 1) left atrium, 2) midcavitary left ventri-
cle, 3) left ventricular outflow tract, and 4) left ventricular
apex (Fig. 2). In addition, peak video intensity measure-
ments could also be used to determine the reproducibility
and repeatability of the methods. This was carried out for
two contrast agents, specifically, sonicated Renografin-76
and sonicated sorbitol 70%. Thereafter, in the instances
where myocardial opacification of echo contrast was noted
after the contrast injection, the appearance of myocardial
contrast was determined by the method just described (Fig.
3). The so-called washout half life of the echo contrast from
the left ventricle was calculatedfrom the constructedcurves
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Figure 2. Long-axis two-dimensional echocardio-
graphic Image (stop frame) from the left ventncle
showing the appearance of echo contrast at the left
SIdeof the heart (reversed image) The rightpanel
shows the actual constructed appearance and dis-
appearance curves at the four regions of mterest 1)
left atnum, 2) rmdcavitary left ventncle, 3) left
ventncular outflow tract, and 4) left ventncular apex
IVS = mterventncular septum, LVPW = left ven-
tncular postenor wall
(6) Numencal values for these half-lives of the rmdcavitary
left ventncle were correlated with thermodilution cardiac
output measurements In 14 Instances We did not attempt
to calculate myocardial washout or study left to nght shunts
and valvular Incompetence by this method
Results
Extravasation of echocontrast agent. In mne dogs 152
mjections were performed Left ventncular chamber opac-
ification was noted In all cases, although the degree of
opacification vaned between 1+ and 3 + Hemodynamic
and electrocardrographic changes are reported In Table 2
In 3 (2%) of the 152 studies, extravasation of echo contrast
was noted on fluoroscopy, but did not extend beyond the
SIteof Injection Thus, extravasation In Dog 2 occurred after
a total dosage of 96 cc of Renografin-76 (4 cc/kg) The
actual extravasation occurred after a hand injection at a rate
of 4 ccls with the catheter In the deep wedge position In
Dog 3, extravasation was noted after a total dosage of 75
cc of Renografin-76 following an injection of 8 cc at a rate
of 8 ccls with an Inflated balloon In a penpheral branch of
the pulmonary artery In Dog 7, damage of the vessel wall
was found to be due to the catheter tip which remained In
a pulmonary wedge position for 5 hours All fluOroSCOPIC
findings were confirmed by microscopic analysis, WhICh
showed appearance of methylene blue dye extravasated In
the lung only at the SIte of Injection No damage to the
vascular wall Itself could be detected
Reproducibility and repeatability. In all 152 studies,
two observers Independently concluded that echo contrast
had appeared on the left Side after an Injection In 107 (71%)
Figure 3. Long-axis two-dimensional echocardio-
graphic Image of the left ventncle (LV), showing
the presence of echo contrast in the left ventncular
myocardium (septal and posterolateral myocar-
drum) (arrows) after pulmonary wedge mjection
(bottom) MV = nutral valve, other abbreviations
as m FIgure I
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Table 2. Hemodynamic and Electrocardiographic Changes
After Echo Contrast Injection
AoP = aortic pressure, CO = cardiac output, ECG = electrocardio-
gram, NS = not sigrnficant, p = probability. PAP = pulmonary artery
pressure
of the 152 studies, the two observers also agreed on the
degree of left ventncular chamber opacification This agree-
ment was achieved regardless of the echo contrast agent,
type of catheter or SIte of contrast mjecnon used Intraob-
server agreement for IS selected studies analyzed within 4
days of each other was 100% for the presence of echo
contrast 10 the left ventncular chamber but only 64% 10
terms of the degree of opacification Analysis of peak Video
intensity for 10 duphcate injections of sonicated Renografin-
76 and sonicated sorbitol 70% 10 the same region of interest
10 the midcavity of the left ventncle mdicated a mean percent
error of 10 4 ± 2 I% for sonicated Renografin-76 and I 4
± 0 8% for sonicated sorbitol 70% In two dogs, 12 con-
secutive mjecnons of sonicated Renografin-76 and 12 10-
jections of sonicated sorbitol 70% were reviewed indepen-
dently by two observers Complete agreement was present
between these observers for the degree of left ventncular
opacification for the first and last injection In these studies,
peak VIdeo intensity decreased by 15.1 ± 2 3% for the two
echo contrast agents Hand-agitated agents show a stnkmg
decrease of 50% 10 VIdeo mtensity after as few as three
consecutive mjections and, therefore, were not incorporated
10 the analysis further
Right to left pathway of echo contrast. In four exper-
iments, the pathway of the echo contrast was monitored by
continuous fluoroscopy after a pulmonary capillary injection
of sonicated Renografin-76 Dunng inflation of the balloon,
no flow was noted, whereas flow suddenly appeared after
the balloon was deflated Injection at a more proximal po-
sition showed retrograde flow back into the mam pulmonary
artery ThIS retrograde flow did not influence the degree of
left ventncular opacification TIme from appearance of the
echo contrast at the trp of the catheter 10 the pulmonary
artery to appearance 10 the left atnum was 6 2 ± 4 8 seconds
for sonicated Renografin-76 and 2 8 ± 0 6 seconds for
sonicated sorbitol 70% (probability [p] < 0.05) Whenever
vascular damage was encountered, the transit time decreased
to I 4 ± 0 2 seconds for both agents studied (p < 0 05)
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Figure 4. Relation between calculated left ventncular echo con-
trast "washout" (from rmdcavitary [MClleft ventncle) and cardiac
output (thermodilution) III 14 expenments The correlation IS fair
(r = -078) See text for further explanation TI/2 = half-life
FluOroSCOPIC control dunng mjections of sorncated Reno-
grafin-76 showed that the echo contrast agents always fol-
lowed the pulmonary vascular pathway Without evidence of
pulmonary shunting
After echo contrast appeared In the left atrium, It fol-
lowed the bloodstream directly to the left ventricle during
early diastole The mainstream of rmcrobubbles turned into
the left ventncular outflow tract, whereas a smaller stream
went behind the postenor mitral valve leaflet and a relatively
larger stream propagated to the left ventncular apex along
the septal and posterolateral myocardial surfaces (FIg 2)
Dunng systole, the rmcrobubbles appeared to follow a CIr-
cular pattern 10 the left atnum (FIg I) Whenever the en-
docardial outlme was not well dehneated (12 instances), the
echo contrast enhanced the Images In 24 of the 152 studies,
echo contrast appeared 10 the left ventncular myocardium
(FIg 3) Specifically, hand mjections at 4 ccls through the
7F USCI or the 8F Swan-Ganz catheter were most successful
(17 of 24 studies) No attempts were made to show left to
nght cardiac shunts or aortic and mitral regurgitation
Analysis by videodensitometry. From the curves of 4
of the 152 mdividual studies, It was seen that intensity of
echo contrast reached a peak 10 the left ventncular apex 300
± 100 ms after the peak had appeared 10 the left atnum
In all instances, peak mtensity 10 the left atnum was ob-
served 200 ± 60 ms before It was determmed 10 the outflow
tract of the left ventncle The echo contrast VIdeo intensity
of the rmdcavitary left ventncle and thermodilution cardiac
output curves had a morphologic smulanty FIgure 4 shows
the relation between cardiac output and numencal half-life
of echo contrast 10 the midcavitary left ventncle Correlation
coefficient was fair (r = - 0 78)
In 24 instances where the appearance of echo contrast
was noted VIsually after an intrapulmonary injection (FIg
3), ItS appearance could be proven by an mcrease 10 peak
VIdeo intensity of the left ventricular myocardium Prefer-
able regions where myocardial echo contrast was noted were
the posterolateral wall and mterventncular septum
p Value
After
Injection
15/5 to 20/5 NS
135/90 to 160/90 NS
38 to 4 4 NS
No change In ST-T segment, but
short SinUS bradycardia or
SinUS tachycardia dunng
mjections
Before
Injecuon
15/5 to 25/7
140/90 to 160/90
38 to 44
PAP (mm Hg)
AoP (rnrn Hg)
CO (hters/rmn)
ECG
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Discussion
The present study indicates that opacrfication of the left
ventncular chamber with echo contrast from a nght-sided
pulmonary wedge mjection site is feasible, causes no major
side effects aside from rnmor extravasation and IS repro-
ducible The procedure required a peripheral pulmonary
artery mjecnon with an Inflated balloon, followed by a flush
injection WIth a deflated balloon ThIS procedure can be
accomplished USIng echo contrast agents WIth small micro-
bubble sizes and commercially available flow-directed cath-
eters We also showed that the hand-agitated contrast agents,
which have larger rmcrobubbles and are more unstable , were
more unreliable to use, because the degree of left ventncular
opacificanon vaned greatly from mjecnon to injection.
Catheter diameter appears to be an Important factor that
hrrnts the ultimate outcome, however, SIte of mjection, rate
of mjection and pressure of mjection did not influence our
data
Toxicity. Although we observed an extravasation of echo
contrast In only 3 of 152 studies, certam precautions are
needed for the procedure. We found that a firmly wedged
catheter pOSItIOn for a prolonged penod of time was unde-
sirable Furthermore, we avoided keeping the balloon In-
flated between consecutive studies. Such precautions are
generally accepted when flow-directed catheters are used.
The most suitable SIteappears to be a penpheral pulmonary
artery branch where pulmonary artery pressure could be
registered WIth the balloon deflated.
Echo contrast properties. To our knowledge, this IS
the first study that showed the feasibihty of left ventncular
chamber and myocardial opacification and systematically
deterrnmed all the possible van abies that could have mflu-
enced the ultimate results. The only other study (2) that
showed that left ventncular chamber echo contrast opaci-
fication from a right-sided pulmonary wedge pOSItIOn was
feasible did not provide these data
The ultimate success of our studies was sigmficantly de-
termmed by the physical properties of the contrast agent.
Because the rmcrobubbles used In the present study are small
and persist longer, the potentially dangerous power mjec-
nons to squeeze the echo contrast agents through the cap-
illanes (2) could have been avoided ThIS IS clear from our
calculated pulmonary transit times of both sonicated Ren-
ografin-76 and sorbitol 70%, WhICh are different from those
observed by Serruys et al (2). The latter Investigators found
a pulmonary transit time of 500 ms, WhICh was sigruficantly
shorter than the physiologic value of 2 seconds (8). The
present study showed the Importance of small microbubble
SIze for passing the capillary circulation because the larger
rrucrobubbles (Renografin-76)had a significantly longer transit
time than did sorbitol 70% . Imnal attempts In this laboratory
have shown that the large microbubbles temporanly obstruct
capillary flow, explammg Its longer transit time Both the
small size of the rmcrobubbles and the sufficient persistence
to show left ventncular opacification after an Intrapulmonary
injection are properties required for an agent to be used In
myocardial contrast studies
Potential application. Our observations of left ventnc-
ular and left atnal bloodstream patterns are In agreement
WIth other earlier studies USIng different methods (9) Our
prelmunary analysis to calculate echo contrast disappear-
ance and appearance curves for several regions of Interest
In the left ventncular chamber yielded an echo contrast
washout half-life that correlated fairly well WIth thermo-
dilunon cardiac output ThIS IS not surpnsmg and reflects
earlier unsuccessful attempts USIng other sites of injection
(10) We could not correct for the Inherent disappearance
rate of rmcrobubbles, and this WIll probably significantly
influence future attempts to quantitate myocardial contrast
echocardiography.
Our data and those of others (11) have shown that blood-
stream patterns are altered In the presence of large areas of
myocardial dysfunction The echo contrast method may pro-
VIde a potentIal tool to study the different flow patterns when
formation of a thrombus occurs after acute myocardial In-
farction A contrast-enhanced endocardial outlme will have
practIcal advantage In cluneal CIrcumstances In which only
technically marginal Images can be obtamed The success
rate of myocardial opacificatron and the appearance of echo
contrast are as yet not predictable and the contrast effect
was not characteristic, nevertheless, outline of myocardial
perfusion defects from a right-sided injection of the echo
contrast agents used In the present study should be possible
(FIg 3)
Conclusion. We have descnbed and demonstrated a rel-
anvely nontoxic and reproducible method to obtain left
ventricular chamber contrast Images from a pulmonary wedge
position In anesthetIzed dogs, USIng echo contrast agents
WIth supenor physical propernes In a small number (16%)
of studies, myocardial opacification was also feasible The
potentIal apphcanons are quahtanve determmation of left
ventncular and left atnal bloodstream patterns and quann-
tative measurements of left ventncular chamber and myo-
cardial echo contrast washout rates Provided that our find-
mgs can be extended and confirmed by other Investigators,
contrast two-dimensional echocardiography IS an exerting
technique for the future Further development of techniques
to opacify the left ventncular chamber and myocardlU~
through pulmonary artery or Intravenous mjections IS
warranted
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